Chimerix Inc (CMRX)
0.895
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.895
0.00 (0.00%)
After-Hours: 20:00
Chimerix Enterprise Value: -103.22M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | -103.22M |
April 24, 2024 | -101.89M |
April 23, 2024 | -100.16M |
April 22, 2024 | -101.18M |
April 19, 2024 | -103.81M |
April 18, 2024 | -99.54M |
April 17, 2024 | -102.06M |
April 16, 2024 | -100.63M |
April 15, 2024 | -101.12M |
April 12, 2024 | -97.01M |
April 11, 2024 | -94.39M |
April 10, 2024 | -93.59M |
April 09, 2024 | -94.39M |
April 08, 2024 | -93.50M |
April 05, 2024 | -90.82M |
April 04, 2024 | -89.93M |
April 03, 2024 | -89.93M |
April 02, 2024 | -92.61M |
April 01, 2024 | -89.04M |
March 28, 2024 | -88.15M |
March 27, 2024 | -92.61M |
March 26, 2024 | -94.39M |
March 25, 2024 | -94.88M |
March 22, 2024 | -93.52M |
March 21, 2024 | -97.42M |
Date | Value |
---|---|
March 20, 2024 | -94.39M |
March 19, 2024 | -97.07M |
March 18, 2024 | -84.58M |
March 15, 2024 | -80.12M |
March 14, 2024 | -81.01M |
March 13, 2024 | -78.33M |
March 12, 2024 | -77.44M |
March 11, 2024 | -72.09M |
March 08, 2024 | -70.30M |
March 07, 2024 | -70.30M |
March 06, 2024 | -71.20M |
March 05, 2024 | -74.77M |
March 04, 2024 | -77.44M |
March 01, 2024 | -78.33M |
February 29, 2024 | -80.12M |
February 28, 2024 | -72.09M |
February 27, 2024 | -75.21M |
February 26, 2024 | -76.55M |
February 23, 2024 | -77.44M |
February 22, 2024 | -77.77M |
February 21, 2024 | -76.88M |
February 20, 2024 | -74.22M |
February 16, 2024 | -80.44M |
February 15, 2024 | -90.22M |
February 14, 2024 | -89.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-137.34M
Minimum
Oct 20 2022
878.07M
Maximum
Feb 17 2021
129.37M
Average
30.64M
Median
Jul 11 2019
Enterprise Value Benchmarks
UFP Technologies Inc | 1.629B |
Dentsply Sirona Inc | 8.078B |
Arbutus Biopharma Corp | 364.07M |
Pacira BioSciences Inc | 1.430B |
Karyopharm Therapeutics Inc | 101.45M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -18.16M |
Revenue (Quarterly) | 0.004M |
Total Expenses (Quarterly) | 20.81M |
EPS Diluted (Quarterly) | -0.21 |
Profit Margin (Quarterly) | -454.0K% |
Earnings Yield | -103.9% |
Normalized Earnings Yield | -103.91 |